KFDA requires additional warning for co-administration of 30 medicines

Published: 2010-05-27 06:55:00

Updated: 2010-05-27 06:55:00

The concomitant therapy of 30 drugs carries the risks of side effects, and from now on, the Korea Food and Drug Administration (KFDA) says those risks have to be spelled out in detail on the product labels.

The drug agency issued an additional rule that requires manufacturers of 30 pharmaceuti...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK